MedPath

Comparison of continuous infusion of valproate vs midazolam in children aged 3months to 18 years of refractory seizures.

Phase 3
Conditions
Health Condition 1: G042- Bacterial meningoencephalitis andmeningomyelitis, not elsewhere classified
Registration Number
CTRI/2024/07/069881
Lead Sponsor
Meera Mohan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children admitted with refractory seizures ( no response even after 2 antiepileptics) in children aged 3 months to 18 years in PICU.

Exclusion Criteria

Child with metabolic disorders are not included in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in seizure burden <br/ ><br>2. Adequacy of seizure control <br/ ><br>3. Rapidity of seizure control <br/ ><br>4. Adverse effects <br/ ><br>Timepoint: 30 minutes
Secondary Outcome Measures
NameTimeMethod
Adverse effects of drugsTimepoint: 1 week
© Copyright 2025. All Rights Reserved by MedPath